Breast Milk Expression
Conditions
Keywords
Breastfeeding, Galactogogue, Plant extracts, Probiotics
Brief summary
The objective of this trial is to evaluate the effect of the consumption of a combination of probiotic strains (Prob-milk) and of a combination of plant extracts plus an inactivated probiotic strain (VoluntasProb) on the production volume and the nutritional composition and the microbiota. of breast milk in lactating women.
Detailed description
Previous studies have shown the galactogogue effect of fenugreek, fennel, and milk thistle. However, to date no study has considered the evaluation of all three extracts. Additionally, certain probiotic strains of Lactobacillus and Bifidobacterium also appear to increase milk production in animal studies. The objective of this trial is to evaluate the effect of the consumption of a combination of probiotic strains (Prob-milk) and of a combination of plant extracts plus an inactivated probiotic strain (VoluntasProb) on the production volume and the nutritional composition and the microbiota. of breast milk in lactating women. This is a preliminary study whose purpose is to gather information for future studies.
Interventions
DIETARY_SUPPLEMENTPlacebo
Each participant will consume 6 capsules daily, 2 in every meal, without any restriction in the diet nor in their habits of life.
DIETARY_SUPPLEMENTProb-milk
Each participant will consume 6 capsules daily, 2 in every meal, without any restriction in the diet nor in their habits of life.
DIETARY_SUPPLEMENTVoluntas-Prob
Each participant will consume 6 capsules daily, 2 in every meal, without any restriction in the diet nor in their habits of life.
Sponsors
Biosearch S.A.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
1. Lactating women between 18 and 45 years old, who have given birth to a healthy baby at term (born between 37 and 42 weeks). 2. Who have the perception of having little volume of milk or a nutritional composition of milk that is not adequate for their baby 3. That they are between week 2 and week 6 of breastfeeding, and that at the time of beginning the study they are not supplementing with formula milk the feeding of their baby. 4. That they have the firm intention of breastfeeding for 28 more days. 5. Women who agree to participate and have read, understood and signed the informed consent
Exclusion criteria
1. Suffering from any disease that may hinder or prevent breastfeeding 2. Being currently consuming or having consumed in the two weeks prior to the study a probiotic or a supplement with plant extracts. 3. Being consuming any drug that can alter the volume or composition of breast milk. 4. Have an allergy to any antibiotics or peanuts 5. Have an allergy to any of the components of the products under study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Microbiota of breast milk | 28 days | Load of Lactobacillus, Bifidobacterium, Staphylococcus, Streptococcus in breast milk |
| Volume of breast milk | 28 days | The volume of breast milk production will be measured as the difference in weight in grams of the child before and after the first and last feeding of the day, measured on two consecutive days. It should be collected on the first two days before starting treatment and two days in a row separated by one week during treatment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of IgA in breast milk | 28 days | Analysis of the concentration of IgA (ug/mL) in breast milk |
| Baby feces microbiota | 28 days | Presence of Lactobacillus spp, Bifidobacterium spp., Streptococcus spp. Staphylococcus spp, Bacteroides spp, E. coli spp, Clostridium spp in baby faeces |
| Baby's anthropometric measures_weight | 28 days | Weight (kg) of the baby at baseline, 14 days and 28 days. |
| Baby's anthropometric measures_height | 28 days | Height (cm) of the baby at baseline, 14 days and 28 days. |
| Baby's anthropometric measures_BMI | 28 days | BMI (kg/m2) of the baby at baseline, 14 days and 28 days. |
| Nutritional composition of breast milk | 28 days | Analysis of the content of proteins, fatty acids profile and total fat content, and iron and calcium content in breast milk |
| Data about the intestinal health of the baby_color of the faeces | 28 days | Data about color of the feces (yellow, mustard, brown, grey, or green) |
| Data about the intestinal health of the baby_consistency of the feces | 28 days | Data about consistency of the feces (hard lumps, sausage with cracks, soft sausage, mushy (like porridge),or watery) |
| Data about sleep parameters of the baby | 28 days | Hours of night sleeping per day and hours of total sleeping during the day |
| Infantile colick symptoms | 28 days | Presence of infantile colick defined as vigorous and inconsolable crying for more than 3 hours a day for at least 3 weeks |
| Data about the intestinal health of the baby_stool frequency | 28 days | Data about stool frequency (times per day) |
| Measurement of IL-8 in breast milk | 28 days | Analysis of the concentration of IL-8 (pg/mL) in breast milk |
Countries
Spain
Outcome results
None listed